$MRAI
Marpai, Inc.

2021 Q4 Form 10-K Financial Statement

#000141057822000657 Filed on March 30, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $5.896M $14.23M $0.00
YoY Change
Cost Of Revenue $4.226M $10.29M $0.00
YoY Change
Gross Profit $1.670M $3.937M $0.00
YoY Change
Gross Profit Margin 28.33% 27.67%
Selling, General & Admin $6.065M $13.02M $1.527M
YoY Change 297.2% 752.73%
% of Gross Profit 363.15% 330.71%
Research & Development $615.8K $1.734M $1.841M
YoY Change -66.55% -1.84%
% of Gross Profit 36.87% 44.04%
Depreciation & Amortization $738.5K $1.962M $36.49K
YoY Change 1923.9% 2537.31%
% of Gross Profit 44.22% 49.83%
Operating Expenses $7.419M $14.75M $3.368M
YoY Change 120.31% 348.02%
Operating Profit -$5.749M -$15.86M -$3.368M
YoY Change 70.72% 370.98%
Interest Expense -$42.79K $427.2K -$526.1K
YoY Change -91.87% -18.03%
% of Operating Profit
Other Income/Expense, Net $63.45K $172.5K $25.85K
YoY Change 145.45% 567.46%
Pretax Income -$5.729M -$16.13M -$3.868M
YoY Change 48.1% 317.14%
Income Tax $0.00 -$150.0K $0.00
% Of Pretax Income
Net Earnings -$5.729M -$15.98M -$3.868M
YoY Change 48.1% 313.26%
Net Earnings / Revenue -97.16% -112.36%
Basic Earnings Per Share -$1.59
Diluted Earnings Per Share -$568.5K -$1.59 -$269.9K
COMMON SHARES
Basic Shares Outstanding 20.12M 10.08M
Diluted Shares Outstanding 10.08M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.18M $19.18M
YoY Change 993.32%
Cash & Equivalents $19.18M $19.18M $1.755M
Short-Term Investments
Other Short-Term Assets $7.494M $7.494M
YoY Change 2201.73%
Inventory
Prepaid Expenses
Receivables $208.8K $223.7K
Other Receivables $91.50K $91.50K
Total Short-Term Assets $26.99M $26.99M $2.180M
YoY Change 1138.06% 1138.06%
LONG-TERM ASSETS
Property, Plant & Equipment $889.9K $2.934M $195.4K
YoY Change 355.43% 450.68%
Goodwill $2.383M
YoY Change
Intangibles $5.508M
YoY Change
Long-Term Investments
YoY Change
Other Assets $80.61K $80.61K
YoY Change
Total Long-Term Assets $17.21M $17.21M $4.352M
YoY Change 295.47% 295.47%
TOTAL ASSETS
Total Short-Term Assets $26.99M $26.99M $2.180M
Total Long-Term Assets $17.21M $17.21M $4.352M
Total Assets $44.20M $44.20M $6.532M
YoY Change 576.71% 576.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.126M $1.126M $159.2K
YoY Change 607.37% 543.78%
Accrued Expenses $2.525M $8.851M $268.0K
YoY Change 842.29% 2328.55%
Deferred Revenue
YoY Change
Short-Term Debt $3.000M $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0%
Total Short-Term Liabilities $11.15M $11.15M $2.649M
YoY Change 320.71% 320.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $45.00K $1.347M
YoY Change 375.46%
Total Long-Term Liabilities $45.00K $1.347M
YoY Change -81.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.15M $11.15M $2.649M
Total Long-Term Liabilities $45.00K $1.347M
Total Liabilities $14.49M $14.49M $10.03M
YoY Change 44.52% 44.52%
SHAREHOLDERS EQUITY
Retained Earnings -$21.53M -$5.541M
YoY Change 288.49%
Common Stock $2.030K $14.00
YoY Change 14400.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $29.71M $29.71M -$3.496M
YoY Change
Total Liabilities & Shareholders Equity $44.20M $44.20M $6.532M
YoY Change 576.71% 576.71%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$5.729M -$15.98M -$3.868M
YoY Change 48.1% 313.26%
Depreciation, Depletion And Amortization $738.5K $1.962M $36.49K
YoY Change 1923.9% 2537.31%
Cash From Operating Activities -$5.269M -$10.80M -$898.1K
YoY Change 486.65% 453.81%
INVESTING ACTIVITIES
Capital Expenditures -$462.2K $273.4K -$568.6K
YoY Change -18.71% 789.33%
Acquisitions
YoY Change
Other Investing Activities $0.00 $11.38M $45.64K
YoY Change -100.0% 24843.12%
Cash From Investing Activities -$462.2K $9.644M -$522.9K
YoY Change -11.62% -1840.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $24.55M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 22.66M 25.27M 2.475M
YoY Change 815.71% 520.05%
NET CHANGE
Cash From Operating Activities -5.269M -10.80M -898.1K
Cash From Investing Activities -462.2K 9.644M -522.9K
Cash From Financing Activities 22.66M 25.27M 2.475M
Net Change In Cash 16.93M 24.12M 1.054M
YoY Change 1506.59% 1434.41%
FREE CASH FLOW
Cash From Operating Activities -$5.269M -$10.80M -$898.1K
Capital Expenditures -$462.2K $273.4K -$568.6K
Free Cash Flow -$4.807M -$11.07M -$329.5K
YoY Change 1358.6% 459.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10076494
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2428878
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001844392
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 dei Entity Public Float
EntityPublicFloat
0
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20299727
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
142369
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.59
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.60
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-40904
CY2021 dei Entity Registrant Name
EntityRegistrantName
MARPAI INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1916231
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
5701 East Hillsborough Ave., Suite 1417
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33610-5428
CY2021 dei City Area Code
CityAreaCode
646
CY2021 dei Local Phone Number
LocalPhoneNumber
303-3483
CY2021 dei Security12b Title
Security12bTitle
Common Shares, par value $0.0001
CY2021 dei Trading Symbol
TradingSymbol
MRAI
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
96472
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1866237
CY2021Q4 mrai Due To Related Party Current
DueToRelatedPartyCurrent
3637
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
337316
CY2021Q4 us-gaap Goodwill
Goodwill
2382917
CY2020Q4 mrai Due To Related Party Current
DueToRelatedPartyCurrent
243638
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11145388
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2649207
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
7095887
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20299708
CY2021 dei Auditor Firm
AuditorFirmId
1195
CY2021 dei Auditor Name
AuditorName
UHY LLP
CY2021 dei Auditor Location
AuditorLocation
Melville, New York
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19183044
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1754569
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
6750599
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
63363
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
208762
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
14978
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
743126
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
262211
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
91498
CY2020Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
100038
CY2021Q4 us-gaap Assets Current
AssetsCurrent
26992007
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2180181
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
889935
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
195404
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6304854
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3818959
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2043624
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5507693
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
52277
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28333
CY2021Q4 us-gaap Assets
Assets
44201640
CY2020Q4 us-gaap Assets
Assets
6531860
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1125906
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
159168
CY2020Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
15725
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2525037
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
267967
CY2021Q4 mrai Accrued Fiduciary Obligations Current
AccruedFiduciaryObligationsCurrent
5541067
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1165248
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
784493
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1301828
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
283265
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2001012
CY2020 us-gaap Interest Expense
InterestExpense
521140
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-18922
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1499376
CY2021 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
10289578
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8055572
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4959
CY2021Q4 us-gaap Liabilities
Liabilities
14493228
CY2020Q4 us-gaap Liabilities
Liabilities
10028359
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
227791050
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
227791050
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20299727
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
142369
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2030
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
14
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51232092
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2044362
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21525710
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5540875
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29708412
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-3496499
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44201640
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6531860
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14226794
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4965209
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27583
CY2021 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2492060
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1733964
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1766388
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1961733
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
74384
CY2021 mrai Facilities Expense
FacilitiesExpense
589926
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
30088042
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
3367731
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-15861248
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-3367731
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
172513
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25846
CY2021 us-gaap Interest Expense
InterestExpense
427178
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16134835
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3867984
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-150000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-15984835
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-3867984
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.59
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.60
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1230792
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1030802
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10076494
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2428878
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-873145
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
213828
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1030802
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-3867984
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-3496499
CY2021 mrai Stock Issued During Period Value Exchange With Subsidiary
StockIssuedDuringPeriodValueExchangeWithSubsidiary
-14
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17351935
CY2021 mrai Stock Issued During Period Value Ipo
StockIssuedDuringPeriodValueIpo
24547085
CY2021 mrai Stock Issued During Period Value Conversion Of Convertible Notes To Common Stock
StockIssuedDuringPeriodValueConversionOfConvertibleNotesToCommonStock
5106554
CY2021 mrai Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
900000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
61
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
53333
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1230792
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-15984835
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29708412
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
CY2021 us-gaap Profit Loss
ProfitLoss
-15984835
CY2020 us-gaap Profit Loss
ProfitLoss
-3867984
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1961733
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
74384
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
100160
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
77983
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
26728
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
102028
CY2021 us-gaap Paid In Kind Interest
PaidInKindInterest
365880
CY2020 us-gaap Paid In Kind Interest
PaidInKindInterest
414654
CY2021 mrai Convertible Notes Issued In Exchange For Services
ConvertibleNotesIssuedInExchangeForServices
-75000
CY2020 mrai Convertible Notes Issued In Exchange For Services
ConvertibleNotesIssuedInExchangeForServices
-50000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-150000
CY2021 mrai Increase Decrease In Accounts Receivable And Unbilled Receivable
IncreaseDecreaseInAccountsReceivableAndUnbilledReceivable
131509
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
349502
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
318380
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-8540
CY2021 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
2592
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
41130
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
114290
CY2021 mrai Increase Decrease In Accounts Payable Related Party
IncreaseDecreaseInAccountsPayableRelatedParty
-15725
CY2020 mrai Increase Decrease In Accounts Payable Related Party
IncreaseDecreaseInAccountsPayableRelatedParty
15725
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
961795
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
200552
CY2021 mrai Increase Decrease In Accrued Fiduciary Obligations
IncreaseDecreaseInAccruedFiduciaryObligations
-1470159
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-99884
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-86971
CY2021 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-240001
CY2020 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
243638
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-39972
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
28333
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10795252
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1949279
CY2021 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
11384035
CY2021 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1463812
CY2020 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
568959
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3050
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
273433
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30746
CY2020 mrai Proceeds From Reimbursement Of Leasehold Improvements From Sublease
ProceedsFromReimbursementOfLeaseholdImprovementsFromSublease
45640
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9643740
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-554065
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
25378663
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
900000
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
783257
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
61
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
550000
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4075000
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
3000000
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
3000000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
831577
CY2021 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
53333
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25267223
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4075000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24115711
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1571656
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1817932
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246276
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25933643
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1817932
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19183044
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1754569
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
6750599
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
63363
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25933643
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1817932
CY2021 mrai Conversion Of Convertible Notes Into Common Stock At Closing Of Acquisition
ConversionOfConvertibleNotesIntoCommonStockAtClosingOfAcquisition
4089921
CY2021 mrai Conversion Of Convertible Notes Into Common Stock At Ipo
ConversionOfConvertibleNotesIntoCommonStockAtIpo
5106554
CY2021 mrai Payments Of Non Cash Activity On Office Improvements
PaymentsOfNonCashActivityOnOfficeImprovements
27567
CY2021 us-gaap Stock Issued1
StockIssued1
8500000
CY2021Q4 mrai Amounts Over Federally Insured Limits
AmountsOverFederallyInsuredLimits
18777000
CY2020Q4 mrai Amounts Over Federally Insured Limits
AmountsOverFederallyInsuredLimits
1505000
CY2021 mrai Losses Incurred To Date On Deposit Balances
LossesIncurredToDateOnDepositBalances
0
CY2021 mrai Number Of Customers Who Accounted For Greater Than Ten Percent Of Accounts Receivable
NumberOfCustomersWhoAccountedForGreaterThanTenPercentOfAccountsReceivable
3
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21525710
CY2021Q4 mrai Working Capital
WorkingCapital
15846619
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
0
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19183044
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates include, but are not limited to, valuation of share-based compensation, valuation of the Company’s common stock prior to the IPO, accounting for warrants, allowance for doubtful accounts, useful lives of internally developed software, fair values of net assets acquired, goodwill, intangible assets and property and equipment, whether an arrangement is or contains a lease, the incremental borrowing rate used for operating leases, income tax accruals, the valuation allowance for deferred income taxes, and contingent liabilities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.</p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains cash accounts with financial institutions. At times, balances in these accounts may exceed federally insured limits. The amounts over the federally insured limits as of December 31, 2021 and 2020 was approximately $18,777,000 and $1,505,000, respectively. No losses have been incurred to date on any deposit balances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the year ended December 31, 2021, no customer accounted for greater than 10% of total revenue. At December 31, 2021, three customers each accounted for 43%, 26% and 24% of accounts receivable, respectively.</p>
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
208762
CY2020 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
14978
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1165248
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
418988
CY2021 mrai Accounts Receivable Payments Term
AccountsReceivablePaymentsTerm
P30D
CY2021 mrai Warrants To Acquire Common Shares
WarrantsToAcquireCommonShares
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Warrants to Acquire Common Shares:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the year ended December 31, 2021, and 2020, respectively, the Company issued warrants to acquire common shares. The Company assessed the warrants pursuant to ASC 480 “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging” and determined that the warrants should be accounted for as equity and not as a derivative liability. Refer to Note 12 for additional information.   </p>
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2556199
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5451501
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021 us-gaap Advertising Expense
AdvertisingExpense
1261296
CY2020 us-gaap Advertising Expense
AdvertisingExpense
27583
CY2021 mrai Business Acquisitions Incremental Amortization Expense Related To Intangible And Tangible Assets Acquired
BusinessAcquisitionsIncrementalAmortizationExpenseRelatedToIntangibleAndTangibleAssetsAcquired
297736
CY2021Q4 mrai Capitalized Computer Software Net Of Accumulated Amortization And In Process
CapitalizedComputerSoftwareNetOfAccumulatedAmortizationAndInProcess
5974844
CY2021 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
18441875
CY2020 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
18388192
CY2021 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-18034702
CY2020 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-17620431
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1185518
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
293191
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
295583
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
97787
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
889935
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
195404
CY2021 us-gaap Depreciation
Depreciation
199649
CY2020 us-gaap Depreciation
Depreciation
74384
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
7161571
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1186727
CY2021Q4 mrai Capitalized Computer Software In Process
CapitalizedComputerSoftwareInProcess
330010
CY2020Q4 mrai Capitalized Computer Software In Process
CapitalizedComputerSoftwareInProcess
3818959
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6304854
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3818959
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1186727
CY2020 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
575357
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
666830
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
114012
CY2021 us-gaap Sublease Income
SubleaseIncome
172476
CY2020 us-gaap Sublease Income
SubleaseIncome
25846
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
886318
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
844618
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
207105
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
198060
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
154500
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2290601
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
204280
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2086321
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
784493
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1301828
CY2021Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P2Y6M29D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06
CY2021Q4 mrai Lessee Operating Lease Amount Expected To Receive Year One
LesseeOperatingLeaseAmountExpectedToReceiveYearOne
229836
CY2021Q4 mrai Lessee Operating Lease Amount Expected To Receive Year Two
LesseeOperatingLeaseAmountExpectedToReceiveYearTwo
186162
CY2021Q4 mrai Lessee Operating Lease Amount Expected To Receive Year Three
LesseeOperatingLeaseAmountExpectedToReceiveYearThree
34807
CY2021Q4 mrai Lessee Operating Lease Amount Expected To Receive Year Four
LesseeOperatingLeaseAmountExpectedToReceiveYearFour
34807
CY2021Q4 mrai Lessee Operating Lease Amount Expected To Receive Year Five
LesseeOperatingLeaseAmountExpectedToReceiveYearFive
29006
CY2021Q4 mrai Lessee Operating Lease Amount Expected To Receive
LesseeOperatingLeaseAmountExpectedToReceive
514618
CY2021Q4 mrai Repayment Of Convertible Debt Accrued Interest
RepaymentOfConvertibleDebtAccruedInterest
783257
CY2021Q4 mrai Repayment Of Convertible Debt Principal Amount
RepaymentOfConvertibleDebtPrincipalAmount
430000
CY2021Q4 mrai Repayments Of Convertible Debt Accrued Interest
RepaymentsOfConvertibleDebtAccruedInterest
353257
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
8555000
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
518924
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
111800
CY2020Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
8962124
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1866237
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
7095887
CY2021Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3000000
CY2021Q3 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.06
CY2021Q3 us-gaap Debt Instrument Term
DebtInstrumentTerm
P6M
CY2021Q3 mrai Threshold Percentage Of Maximum Drawn Principal Amount For Issuance Of Warrants
ThresholdPercentageOfMaximumDrawnPrincipalAmountForIssuanceOfWarrants
0.30
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
3000000
CY2021Q4 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
27083
CY2021Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.00
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.009
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
225000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.201
CY2021 mrai Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
-0.005
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.005
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.009
CY2021Q4 mrai Deferred Tax Assets Startup Costs
DeferredTaxAssetsStartupCosts
1001272
CY2020Q4 mrai Deferred Tax Assets Startup Costs
DeferredTaxAssetsStartupCosts
463690
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
584881
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
434384
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
2244367
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
101451
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
522491
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
46209
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
174289
CY2021Q4 mrai Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
1682939
CY2021Q4 mrai Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
333501
CY2021Q4 mrai Deferred Tax Assets Operating Lease Assets
DeferredTaxAssetsOperatingLeaseAssets
393985
CY2021Q4 mrai Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
350236
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2467111
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1045734
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4468123
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1045734
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2001012
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4
CY2021Q4 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
900000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
0
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4468123
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
17129023
CY2020Q4 us-gaap Noncurrent Assets
NoncurrentAssets
4351679
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
297267
CY2020Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
16000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3637
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
243638
CY2021 mrai Related Party Reimbursement Expenses
RelatedPartyReimbursementExpenses
465000
CY2020 mrai Related Party Reimbursement Expenses
RelatedPartyReimbursementExpenses
10613
CY2021 mrai Percentage On Monthly Salary Under Severance Pay Law
PercentageOnMonthlySalaryUnderSeverancePayLaw
0.0833
CY2021 us-gaap Severance Costs1
SeveranceCosts1
132031
CY2020 us-gaap Severance Costs1
SeveranceCosts1
79931
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
897288
CY2020Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
223012
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
743038
CY2021Q4 mrai Performance Guarantee Liabilities Current
PerformanceGuaranteeLiabilitiesCurrent
418988
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
465723
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
44955
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2525037
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
267967
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24547086
CY2021Q4 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
783257

Files In Submission

Name View Source Status
0001410578-22-000657-index-headers.html Edgar Link pending
0001410578-22-000657-index.html Edgar Link pending
0001410578-22-000657.txt Edgar Link pending
0001410578-22-000657-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrai-20211231.xsd Edgar Link pending
mrai-20211231x10k.htm Edgar Link pending
mrai-20211231x10k001.jpg Edgar Link pending
mrai-20211231x10k002.jpg Edgar Link pending
mrai-20211231x10k006.jpg Edgar Link pending
mrai-20211231x10k_htm.xml Edgar Link completed
mrai-20211231xex10d14.htm Edgar Link pending
mrai-20211231xex10d29.htm Edgar Link pending
mrai-20211231xex10d30.htm Edgar Link pending
mrai-20211231xex21d1.htm Edgar Link pending
mrai-20211231xex31d1.htm Edgar Link pending
mrai-20211231xex31d2.htm Edgar Link pending
mrai-20211231xex32d1.htm Edgar Link pending
mrai-20211231xex32d2.htm Edgar Link pending
mrai-20211231xex4d68.htm Edgar Link pending
mrai-20211231_cal.xml Edgar Link unprocessable
mrai-20211231_def.xml Edgar Link unprocessable
mrai-20211231_lab.xml Edgar Link unprocessable
mrai-20211231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending